CA-CALDERA-MEDICAL
27.6.2024 15:01:29 CEST | Business Wire | Press release
Caldera Medical, a global leader in women’s pelvic health, is proud to announce its sponsorship of the Cynisca Cycling team. This partnership reflects Caldera Medical’s unwavering commitment to advancing women’s health and empowerment through sports and community engagement.
Cynisca Cycling, an elite women's professional cycling team, is dedicated to elevating female athletes and promoting gender equality in sports. The collaboration with Caldera Medical, renowned for its humanitarian efforts in women's health, is poised to drive significant impact in both the sporting and healthcare arenas.
“We’re extremely pleased to share this new development between our team and Caldera Medical,” commented Robin Farina, Cynisca operations and performance director. “Just like Cynisca, Caldera has made a commitment to advancing women. Through our collaboration, we’ll continue to support women both on and off the bike.”
“Our sponsorship of Cynisca Cycling aligns perfectly with Caldera Medical’s mission to enhance the quality of life for women around the world,” said Bryon Merade, CEO of Caldera Medical. “We believe that empowering women in sports contributes to their overall well-being and health. By supporting Cynisca Cycling, we aim to underscore the importance of physical activity, resilience, and community for women's health.”
Caldera Medical’s involvement with Cynisca Cycling will include:
Health and Wellness Workshops: Organizing workshops focused on pelvic health, mental wellness, and overall physical health for the athletes and their communities.
Awareness Campaigns: Launching joint campaigns to educate the public about women's health issues and the importance of regular check-ups and active lifestyles.
Community Engagement: Participating in community events and activities that promote women's health and empowerment.
This sponsorship represents a significant step in Caldera Medical’s broader mission to address and improve women's health globally. The partnership with Cynisca Cycling will provide a dynamic platform to promote health, fitness, and empowerment among women, resonating with Caldera’s core values of compassion, excellence, and innovation.
About Caldera Medical
Caldera Medical is a medical device company solely focused on women’s health with a commitment to our mission of “Improving the Quality of Life for Women!” Caldera Medical develops, manufactures and markets best-in-class surgical products for the treatment of Stress Urinary Incontinence, Pelvic Organ Prolapse Polyps and Fibroids.
Caldera Medical forms close relationships with surgeons and continues to build the company around a principle of customer intimacy. In partnership with its surgeon customers, Caldera Medical has the largest humanitarian program of any women’s health company. It is committed to treating one million women in underserved populations around the world by the year 2027.
About Cynisca Cycling
Cynisca Cycling is a UCI-registered Women’s Continental Team (CYN-USA), dedicated to providing inspiration and support for women to reach the highest levels in cycling - both on and off the bike. The team provides professional support and guidance around a select racing program at the top European and U.S. events.
Launched in 2022 in partnership with USA Cycling, the team began racing in 2023 with an international roster now featuring twelve select North American riders who hold three national titles and a Pan American championship title. Other countries represented include France, Ireland, and Canada. Cynisca is committed to fair pay for female athletes and to providing employment opportunities for women.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240627021263/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
euNetworks launches new quantum-safe private connectivity service powered by Adtran’s encrypted optical transport technology27.5.2026 10:00:00 CEST | Press release
News summary: Developed by euNetworks to deliver the highest levels of protection for sensitive data moving between European data centers Built on Adtran’s solution, euNetworks’ new Quantum Shield service enables quantum-safe encryption across private high-capacity connectivity, with continuous optical and fiber plant monitoring The new offering supports regulated industries with strong assurance against current and emerging cybersecurity threats Adtran and euNetworks today announced their collaboration on the launch of a new quantum-safe private connectivity service, Quantum Shield. euNetworks has developed Quantum Shield using Adtran’s optical transport technology to augment its broader architecture, which is designed to deliver secure, scalable data center connectivity across euNetworks’ pan-European network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526610601/en/ Adtran’s encrypted optical transport technology is
National Bank of Greece in Cyprus Goes Live With Smartstream’s Air to Consolidate Reconciliations27.5.2026 09:55:00 CEST | Press release
Key Facts National Bank of Greece in Cyprus has consolidated four previously separate reconciliations systems – Instant, Cash, SEPA, and Nostro reconciliations – into a single platform using Smartstream’s Air Cash modules. Smartstream Air’s AI-enabled capabilities significantly reduce daily manual effort, eliminate the need to work with multiple data formats, and proactively identify data quality issues from both internal sources and bank statements. Successfully deployed in three months with no existing technology to replace; Smartstream developed a custom automated encrypted file transfer solution to meet the bank’s strict data security requirements. Smartstream, the trusted data solutions provider for leading global financial institutions and enterprises, today announces that the National Bank of Greece (NBG) in Cyprus has successfully gone live with Air, the company’s AI-enabled reconciliation solution. The go-live marks a significant step forward in the bank’s operational efficien
Duco Launches the First Agentic Operations Platform for Financial Services27.5.2026 09:20:00 CEST | Press release
Duco, today launched the first agentic Operations platform for financial services. Built on the engine that already processes 20 billion transactions every month for more than 200 clients, including seven of the top 20 banks and ten of the top 20 asset managers, the platform brings together everything firms need to run post-trade Operations alongside autonomous agents, safely and at scale. The launch establishes a breakthrough the industry has been waiting for. A tool surface, purpose-built for agents. Duco has unbundled its platform into a new alternative agent layer that reconfigures its platform into hundreds of discrete capabilities servicing post trade. Model Context Protocol (MCP) gives capabilities covering reconciliation, data preparation, data access, audit trails, exception management, document creation and more. For the first time, agents have a verified, deterministic toolset built specifically for post-trade. Agents do not replace matching, rules or audit; they use them. P
Brenus Pharma Announces FDA Acceptance of IND Application for STC-1010 (BreAK-CRC001) in MSS Metastatic Colorectal Cancer (mCRC)27.5.2026 08:49:00 CEST | Press release
STC-1010 is a first-in-class allogeneic in vivo immunotherapy for which the FDA has authorized clinical evaluation in the U.S. under the BreAK-CRC001 study. This strategic milestone enables the company to execute a global clinical strategy following European regulatory approvals (ANSM, AFMPS), first patients dosed with preliminary results and good tolerability observed in early Phase Ia. First data are expected to be presented during ESMO annual congress 2026. Brenus Pharma, a clinical stage biotechnology company developing novel in vivo immunotherapies for solid tumors, announced that the U.S. Food and Drug Administration (FDA) has accept the company's Investigational New Drug (IND) application for its first drug candidate, STC-1010, in microsatellite stable (MSS) metastatic colorectal cancer (mCRC). STC-1010 is designed to address a critical unmet need worldwide. Approximately 95% of mCRC patients have MSS tumors, which demonstrate minimal response to standard immunotherapies. The FD
Tide Crosses 2 Million Members Worldwide - Big Step Forward in Mission to Support and Grow Small Businesses27.5.2026 08:00:00 CEST | Press release
Continuing to grow in the UK and internationally, with India seeing especially strong member growth in the last 12 months In the UK, Tide has 15% market share and has helped small businesses access over £1.75bn in credit Rapid roll out of products; from admin, accounting and tax tools; subscription options; payment solutions; government registrations; bill payments and credit Tide, the UK’s leading business management platform, today announces it has crossed 2 million members globally, with India in particular seeing strong growth. More than 1.1 million small businesses joined Tide in India since the company launched there in December 2022. This makes India Tide’s fastest-growing market by member acquisition. The UK is Tide’s home market, with 900,000 SMEs, 15% market share, and the majority of the company’s revenue. Tide’s steadily expanding its presence in Europe, with Germany and France, where the platform is gaining strong traction, thanks to millions of small businesses turning to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
